New Study Warns Meridia Weight Loss Pill Increases Heart Attack, Stroke Risk

People with heart disease who want to lose weight should avoid taking Abbott’s weight loss pill Meridia, according to a new study funded by the drug’s manufacturer.

In Europe, the drug, known as sibutramine, has already been banned because it increases people’s risk of having nonfatal heart attacks and strokes.

An expert advisory committee of the Federal Drug Administration will meet later this month to determine if the United States should implement its own ban.

A article titled, “Weight Loss Pill Meridia Raises Heart Attack, Stroke Risks,”quoted editors of the New England Journal of Medicine as calling Meridia “another flawed diet pill.”

They note that in return for offering a weight loss of under 9 pounds — less than 5% of the body weight of the overweight participants in the study — the drug had a one-in-70 chance of causing a heart attack or stroke.

Since “the modest weight loss with [Meridia] did not translate into clinical benefit,” the editors say, “it is difficult to discern a credible rationale for keeping this medication on the market.”

As an advocate for consumers’ rights, the Simmons law firm will keep you updated on the FDA committee’s recommendations.

Simmons Support Team
Simmons Hanly ConroyWritten by:

Editorial Team

The Simmons Hanly Conroy Editorial Team consists of journalists, writers and editors who strive to deliver accurate and useful information to families needing legal help. Our team works alongside the firm's attorneys and partners, as well as with medical professionals and other specialists, to keep all information relevant and helpful.